AZURRX BIOPHARMA INC's ticker is AZRX and the CUSIP is 05502L105. A total of 18 filers reported holding AZURRX BIOPHARMA INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $926,000 | -29.4% | 544,606 | +0.6% | 0.01% | -35.7% |
| Q1 2019 | $1,311,000 | +101.7% | 541,536 | +0.8% | 0.01% | +55.6% |
| Q4 2018 | $650,000 | -54.5% | 537,429 | -3.4% | 0.01% | -40.0% |
| Q3 2018 | $1,430,000 | -19.8% | 556,537 | +0.2% | 0.02% | -21.1% |
| Q2 2018 | $1,782,000 | – | 555,196 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pensionmark Financial Group, LLC | 130,900 | $94,000 | 0.02% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 168,203 | $225,000 | 0.02% |
| Merrion Investment Management Co, LLC | 14,000 | $18,000 | 0.02% |
| Newman Dignan & Sheerar, Inc. | 23,915 | $32,000 | 0.01% |
| HBW ADVISORY SERVICES LLC | 25,077 | $34,000 | 0.01% |
| Traynor Capital Management, Inc. | 30,000 | $40,000 | 0.01% |
| Virtu Financial LLC | 77,734 | $104,000 | 0.01% |
| Waldron Private Wealth LLC | 69,835 | $93,000 | 0.01% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 100,000 | $134,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 156,120 | $209,000 | 0.00% |